The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer Surgery

Sponsor
Tampere University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05094843
Collaborator
(none)
100
1
83
1.2

Study Details

Study Description

Brief Summary

Lung cancer surgery causes significant changes in the small circulation as well as changes in the intrathoracic anatomy. The effects of lung cancer surgery on electrocardiography and the cardiac stress associated with the procedures have not been previously extensively studied. The aim of the present study is to ascertain whether modern mini-invasive lung cancer surgery causes changes in the electrocardiogram, and whether these changes are transitory during short-term follow-up. Furthermore, the study aims to describe whether lung cancer surgery causes significant cardiac stress detectable by intraoperative electrocardiography.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Lung cancer surgery causes significant acute changes in the small circulation as well as both transient and permanent changes in the intrathoracic anatomy. The electrocardiographic changes as well as their associations with postoperative recovery associated with modern mini-invasive lung cancer surgery have not been extensively studied.

    The aims of the study are:
    1. To define in detail the electrocardiographic changes and their duration caused by lung cancer surgery, both perioperatively and in the early postoperative period

    2. To assess, whether perioperative electrocardiographic changes are associated with the postoperative recovery of these patients.

    Altogether 100 patients with planned mini-invasive lung cancer surgery in the Tays Heart Hospital, Tampere, Finland, will be prospectively recruited for the study between the years 2021 and 2028.

    The 12-lead rest electrocardiogram will be recorded from each patient preoperatively as well daily postoperatively and during follow-up out-patient clinic visit two weeks postoperatively. The perioperative continuous multi-lead electrocardiogram will be recorded. Laboratory examinations (cardiac troponins and natriuretic peptides) indicating cardiac stress will be obtained from the patients preoperatively and repeatedly postoperatively. The variables included in the electrocardiography analysis include cardiac rhythm, heart rate variability, PQ-time, QRS duration, P-, QRS, and T-wave amplitudes and axles, as well as ST-level variations.

    Postoperative complications, including cardiac arrhythmias and myocardial ischemia and the duration of postoperative air leak and postoperative chest tube drainage, will be recorded. The associations between lung cancer surgery and electrocardiographic changes, their duration, as well as their associations with postoperative recovery will be analyzed using statistical methods.

    A local study registry will be established for the study adhering to the legislature and protocols for clinical studies, including data security. Institutional ethics board committee approval has been obtained. The study will be registered in ClinicalTrials.gov prior to patient enrollment. The study does not include any interventions beside the normal treatment of these patients. Written informed consent will be obtained from each patient. The results of the study will be published in international medical journals.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    100 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer Surgery.
    Actual Study Start Date :
    Feb 1, 2022
    Anticipated Primary Completion Date :
    Dec 31, 2028
    Anticipated Study Completion Date :
    Dec 31, 2028

    Outcome Measures

    Primary Outcome Measures

    1. Postoperative electrocardiographic p-, R-, and T-wave amplitude changes [2 weeks]

      Amplitude changes in the 12-lead rest electrocardiography in millimeters, analyzed daily postoperatively.

    2. Postoperative QRS-duration [2 weeks]

      The duration of the QRS-complex in milliseconds in the electrocardiogram, measured daily postoperatively using 12-lead rest electrocardiogram.

    3. Postoperative PQ-delay [2 weeks]

      Changes in the PQ-delay in milliseconds in the 12-lead rest electrocardiogram measured daily postoperatively.

    4. Postoperative QT-interval [2 weeks]

      The duration of QT-interval in milliseconds in the 12-lead rest electrocardiogram measured daily postoperatively.

    5. The postoperative incidence of new bundle branch blocks [2 weeks]

      New complete or partial bundle branch blocks, such as RBBB, in the 12-lead rest electrocardiogram.

    6. Postoperative ST-level changes [3 days]

      ST-level changes in millimeters in the 12-lead rest electrocardiogram

    7. Postoperative P-wave, QRS-complex, and T-wave axle changes [2 weeks]

      The occurrence and type of P-wave, QRS-complex, and T-wave axle changes in the postoperative 12-lead rest electrocardiogram

    8. Postoperative heart rate [1 week]

      Postoperative heart rate variability in continuous electrocardiographic monitoring

    9. Postoperative arrhythmias [1 week]

      Arrhythmia rate as well as their type during the early postoperative period detected by continuous electrocardiogram monitoring

    10. Perioperative ST-level changes [1 day]

      The occurrence, duration (in minutes) as well as the magnitude (in millimeters) of perioperative ST-elevation or depression in the continuous perioperative electrocardiographic monitoring.

    11. Perioperative heart rate variability [1 day]

      Heart rate levels perioperatively in the continuous perioperative electrocardiographic monitoring.

    12. Perioperative arrhythmias [1 day]

      The occurrence and type of perioperative arrhythmias, such as atrial fibrillation or flutter, or ventricular tachycardia in the perioperative electrocardiographic monitoring.

    13. Perioperative R- and T-wave amplitude changes [1 day]

      The amplitude (in millimeters) of possible R- and T-wave amplitude changes in the perioperative electrocardiographic monitoring.

    Secondary Outcome Measures

    1. Postoperative air leak [1 week]

      The presence and duration of (in days) postoperative air leak

    2. Need for reoperation [1 week]

      Need for reoperation due to for example bleeding.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Adult patients scheduled for elective lung cancer surgery

    • Willing to participate in the study

    • Curatively aimed surgery

    • Preoperative decision for mini-invasive surgery

    Exclusion Criteria:
    • Participation in any other clinical trial

    • Previous chronic or paroxysmal atrial fibrillation or atrial flutter

    • Cardiac pacemaker

    • History of cardiac conduction disturbances including bundle branch blocks

    • History of cardiac ablation procedures

    • History of previous surgery in the thoracic area including open heart surgery

    • Preoperatively anticipated need for concomitant thoracic wall resection

    • Preoperatively anticipated need for open surgery

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Heart Hospita, Tampere University Hospital Tampere Pirkanmaa Finland 33580

    Sponsors and Collaborators

    • Tampere University Hospital

    Investigators

    • Principal Investigator: Jahangir Khan, MD, PhD

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Tampere University Hospital
    ClinicalTrials.gov Identifier:
    NCT05094843
    Other Study ID Numbers:
    • R21087
    First Posted:
    Oct 26, 2021
    Last Update Posted:
    May 2, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Tampere University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 2, 2022